Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Healthcare | 17.49% |
| 3 | Consumer Discretionary | 17.05% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lam Research
LRCX
$372B
| $31.2M | 0.03% |
2,294,110
+20,850
| +0.9% | +$299K |
|
|
NEWR
277
DELISTED
New Relic, Inc.
NEWR
| $31.1M | 0.03% |
383,811
+3,389
| +0.9% | +$285K |
|
|
ROIC
278
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $31M | 0.03% |
1,951,190
+18,238
| +0.9% | +$321K |
|
|
AGR
279
DELISTED
Avangrid, Inc.
AGR
| $31M | 0.03% |
617,965
-605,238
| -49% | -$29.7M |
|
280
Laureate Education
LAUR
$5.38B
| $30.8M | 0.03% |
2,023,114
+325,900
| +19% | +$4.88M |
|
|
LJPC
281
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $30.8M | 0.03% |
3,268,744
-10,528
| -0.3% | -$158K |
|
282
Monolithic Power Systems
MPWR
$64.7B
| $30.7M | 0.03% |
263,825
+349
| +0.1% | +$41.8K |
|
283
BioCryst Pharmaceuticals
BCRX
$2.35B
| $30.7M | 0.03% |
3,798,853
-51,150
| -1% | -$398K |
|
284
Neurocrine Biosciences
NBIX
$18.7B
| $30.4M | 0.03% |
426,234
+22,266
| +6% | +$2.13M |
|
285
Clorox
CLX
$11.7B
| $30.4M | 0.03% |
197,216
-60,799
| -24% | -$9.47M |
|
286
Norwegian Cruise Line
NCLH
$8.59B
| $30.2M | 0.03% |
711,292
-443,599
| -38% | -$21.5M |
|
|
NLSN
287
DELISTED
Nielsen Holdings plc
NLSN
| $30.1M | 0.03% |
1,290,796
-74,294
| -5% | -$1.92M |
|
288
Ameris Bancorp
ABCB
$5.88B
| $30.1M | 0.03% |
950,608
+410,379
| +76% | +$16.7M |
|
289
Public Service Enterprise Group
PEG
$38.6B
| $29.6M | 0.03% |
568,454
-753,247
| -57% | -$40.5M |
|
|
DNKN
290
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $29.5M | 0.03% |
460,411
+95,227
| +26% | +$6.77M |
|
|
ZEN
291
DELISTED
ZENDESK INC
ZEN
| $29.5M | 0.03% |
505,433
-50,442
| -9% | -$2.9M |
|
292
Inogen
INGN
$174M
| $28.8M | 0.03% |
232,179
+110,098
| +90% | +$18.1M |
|
293
Cactus
WHD
$4.3B
| $28.8M | 0.03% |
1,050,269
-38,215
| -4% | -$1.25M |
|
294
eBay
EBAY
$50.4B
| $28.7M | 0.03% |
1,023,771
-303,191
| -23% | -$8.92M |
|
295
Plains All American Pipeline
PAA
$17.5B
| $28.7M | 0.03% |
1,431,955
-2,836
| -0.2% | -$64.6K |
|
|
VRNT
296
DELISTED
Verint Systems
VRNT
| $28.4M | 0.03% |
1,318,103
-87,434
| -6% | -$2.01M |
|
297
Hershey
HSY
$35.9B
| $28.3M | 0.03% |
+263,808
| New | +$28M |
|
298
JB Hunt Transport Services
JBHT
$25.3B
| $28.1M | 0.03% |
302,544
-183,974
| -38% | -$19.5M |
|
|
BLUE
299
DELISTED
bluebird bio
BLUE
| $28.1M | 0.03% |
21,877
-18,034
| -45% | -$27.7M |
|
300
Teradata
TDC
$2.88B
| $28M | 0.03% |
730,034
-40,153
| -5% | -$1.47M |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.